PRESS RELEASE published on 10/30/2023 at 13:30, 1 year ago Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Receives Second Tranche of Funding from One Small Planet
PRESS RELEASE published on 10/26/2023 at 14:30, 1 year ago Jaguar Health to Present November 1st at Emerging Growth Conference
PRESS RELEASE published on 10/23/2023 at 14:30, 1 year 1 month ago Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications
PRESS RELEASE published on 10/19/2023 at 14:30, 1 year 1 month ago Independent Study Conducted at Boston Children's Hospital, Harvard Medical School, Shows Potential Utility of Jaguar Health's Crofelemer for Treatment of MVID, a Rare Childhood Disease
PRESS RELEASE published on 10/18/2023 at 14:30, 1 year 1 month ago Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
PRESS RELEASE published on 10/12/2023 at 14:30, 1 year 1 month ago Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
PRESS RELEASE published on 10/10/2023 at 14:30, 1 year 1 month ago Jaguar Animal Health Exhibiting at October 12-14 VCS Annual Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
PRESS RELEASE published on 09/28/2023 at 14:30, 1 year 1 month ago Jaguar Health to Present October 3 at LD Micro's Main Event Investor Conference, and on October 5 at the Global Capital Network Investor Conference
PRESS RELEASE published on 09/27/2023 at 14:30, 1 year 1 month ago Jaguar Health Launches TikTok and Instagram Contest to Raise Awareness About Common Yet Barely Addressed Health Condition: Surprise Diarrhea
PRESS RELEASE published on 09/26/2023 at 14:30, 1 year 1 month ago Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors
Published on 11/22/2024 at 23:55, 1 day 21 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 22 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 22 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 23 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/24/2024 at 19:16, 2 hours 30 minutes ago EQS-Adhoc: RENK Group AG: Termination of mandate of CEO Susanne Wiegand and appointment of Dr. Alexander Sagel as CEO
Published on 11/24/2024 at 19:07, 2 hours 39 minutes ago EQS-Adhoc: ABO Energy KGaA reduces forecast for the 2024 annual result to EUR 20 to 25 million and confirms market expectation for the 2025 financial year
Published on 11/22/2024 at 18:14, 2 days 3 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 2 days 3 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 06:58, 3 days 14 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 2 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 4 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 4 days 4 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
